Cannabinoids cross the placental barrier and can dysregulate the fetal immune system through altered cytokine levels, lymphoid cell death, and epigenetic mechanisms, potentially weakening defenses against infections and cancer later in life.
People interested in cannabis and pregnancy research, fetal development, or immune system effects of cannabinoids.
Cannabinoids cross the placental barrier and may cause epigenetic immune changes in the fetus
What the researchers found
Cannabinoids mediate robust immunomodulation by altering cytokine levels, causing apoptosis of lymphoid cells, and inducing suppressor cells. Maternal exposure during pregnancy could lead to dysregulation of both innate and adaptive immune systems in the developing fetus, with emerging evidence for epigenetic mechanisms causing long-lasting impact.
Why it matters
Cannabis use during pregnancy is increasing, yet the immunological consequences for the developing fetus are poorly understood. This review highlights that cannabinoids don't just cross the placenta but may fundamentally alter how the fetal immune system develops.
The numbers in context
Cannabinoids mediate effects through G-protein coupled CB1 and CB2 receptors. They alter cytokine levels, induce apoptosis of lymphoid cells, and generate immune suppressor cells. Epigenetic mechanisms may cause effects lasting beyond the exposure period.
How the study worked
Review of research on cannabinoid effects on the immune system, focusing on CB1 and CB2 receptor-mediated immunomodulation and its implications for fetal and offspring immune development following in utero exposure.
What this study cannot tell us
Much of the evidence comes from animal models and in vitro studies. Human data on fetal immune effects of cannabinoid exposure are limited. The specific doses and timing that pose risk during pregnancy are not established.
How to read the evidence
Moderate: review synthesizes multiple lines of evidence from both animal and human studies, with consistent biological plausibility.
When this study was published
Published in 2019.
The bigger picture
While much pregnancy-cannabis research focuses on neurological development, the immune system may be equally vulnerable. If in utero cannabinoid exposure weakens immune defenses through epigenetic changes, the consequences might not appear until years later when the child faces infections or cancer risk.
Questions still open
- At what gestational stages is the fetal immune system most vulnerable to cannabinoid exposure? Are the immune effects dose-dependent? Can epigenetic immune changes from in utero exposure be reversed after birth?
Common questions
Can cannabis use during pregnancy affect the baby's immune system?
How long could these immune effects last?
Read the original research
Cannabinoid exposure during pregnancy and its impact on immune function.
Cellular and molecular life sciences : CMLS, 76(4), 729-743
Citation
Dong, Catherine; Chen, Jingwen; Harrington, Amy; Vinod, K Yaragudri; Hegde, Muralidhar L; Hegde, Venkatesh L. (2019). Cannabinoid exposure during pregnancy and its impact on immune function.. Cellular and molecular life sciences : CMLS, 76(4), 729-743. https://doi.org/10.1007/s00018-018-2955-0
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide